Skip to main content

Advertisement

Log in

RETRACTED ARTICLE: Staging in Neuropsychiatry: A Heuristic Model for Understanding, Prevention and Treatment

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

This article was retracted on 06 December 2021

This article has been updated

Abstract

The main mental disorders which develop and persist through adult life typically emerge during the critical developmental phase of adolescence and early adulthood, and are frequently associated with considerable associated distress and functional decline. Our current diagnostic system lacks validity and therapeutic utility, particularly for the early stages of these mental disorders, when symptoms are still evolving and may have not yet stabilised sufficiently to fit familiar or traditional syndromal criteria. Furthermore, there is often difficulty in distinguishing transient developmental or normative changes from the early symptoms of persistent and disabling mental illness. These factors point to the need for reform of our current diagnostic systems. The clinical staging model seeks to define the extent of progression of a disorder at a particular point in time and aims to differentiate early, milder clinical phenomena from those that accompany illness progression and chronicity. The staging framework allows clinicians to select treatments relevant to earlier stages of an illness, and to evaluate their effectiveness in preventing progression and producing remission or return to milder or earlier stages of disorder. For staging to be a valid approach, interventions in the early stages need to shown to be not only more effective but also safer than treatments delivered later in the course of illness. Staging may also allow a more efficient integration of our rapidly expanding knowledge of the biological, social and psychological vulnerability factors involved in development of mental illness into what may ultimately resemble a clinicopathological staging model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Change history

References

  • Addington D, Addington J (2008) First-episode psychosis. In: Mueser KT, Jeste DV (eds) Clinical handbook of schizophrenia. Guildford Press, New York, pp 367–379

    Google Scholar 

  • Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R (2007) North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 33(3):665–672

    PubMed  PubMed Central  Google Scholar 

  • Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE (2010) Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 67(2):146–154

    CAS  PubMed  Google Scholar 

  • Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W (2003) Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 73(1–2):133–146

    PubMed  Google Scholar 

  • Arnett JJ (2004) Emerging adulthood. The winding road from the late teens through the twenties. Oxford University Press, New York

    Google Scholar 

  • Bechdolf A, Wagner M, Veith V, Rurhmann S, Pukrop R, Brockhaus-Dumke A, Berning J, Stamm E, Janssen B, Decker P, Bottlender R, Moller H-J, Gaebel W, Maier W, Klosterkotter J (2007) Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: effects on social adjustment post treatment. Early Interv Psychiatry 1(1):71–78

    PubMed  Google Scholar 

  • Berger G, Dell’Olio M, Amminger GP, Cornblatt BA, Phillips LJ, Yung AR, Yan Y, Berk M, McGorry PD (2007a) Neuroprotection in emerging psychotic disorders. Early Interv Psychiatry 1:114–127

    Google Scholar 

  • Berger GE, Proffitt TM, McConchie M, Yuen H, Wood SJ, Amminger GP, Brewer W, McGorry PD (2007b) Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial. J Clin Psychiatry 68(12):1867–1875

    CAS  PubMed  Google Scholar 

  • Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI (2008) N-acetyl cysteine as a glutathione precursor for schizophrenia–a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 64(5):361–368

    CAS  PubMed  Google Scholar 

  • Bertelsen M, Jeppesen P, Petersen L, Thorup A, Ohlenschlaeger J, le Quach P, Christensen TO, Krarup G, Jorgensen P, Nordentoft M (2008) Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry 65(7):762–771

    PubMed  Google Scholar 

  • Birchwood M (2000) Early intervention and sustaining the management of vulnerability. Aust N Z J Psychiatry 34(Suppl):S181–S184

    PubMed  Google Scholar 

  • Bottlender R, Sato T, Jager M, Groll C, Strauss A, Moller HJ (2002) The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenic and schizoaffective patients. Eur Arch Psychiatry Clin Neurosci 252(5):226–231

    PubMed  Google Scholar 

  • Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R (2008) Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 65(1):28–37

    PubMed  PubMed Central  Google Scholar 

  • Clarke GN, Hornbrook M, Lynch F, Polen M, Gale J, Beardslee W, O’Connor E, Seeley J (2001) A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry 58(12):1127–1134

    CAS  PubMed  Google Scholar 

  • Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E, Lesser ML, Tai JY, Shah MR, Foley CA, Kane JM, Correll CU (2007) Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry 68(4):546–557

    CAS  PubMed  Google Scholar 

  • Correll CU, Penzner JB, Frederickson AM, Richter JJ, Auther AM, Smith CW, Kane JM, Cornblatt BA (2007) Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophr Bull 33(3):703–714

    PubMed  PubMed Central  Google Scholar 

  • Craig TK, Garety P, Power P, Rahaman N, Colbert S, Fornells-Ambrojo M, Dunn G (2004) The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ 329(7474):1067

    PubMed  PubMed Central  Google Scholar 

  • Duffy A, Alda M, Hajek T, Sherry SB, Grof P (2010) Early stages in the development of bipolar disorder. J Affect Disord 121(1–2):127–135

    PubMed  Google Scholar 

  • Eack SM, Hogarty GE, Cooley SS (2009) Cognitive enhancement therapy for early course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv 60:1468–1476

    PubMed  PubMed Central  Google Scholar 

  • Eaton WW, Badawi M, Melton B (1995) Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry 152(7):967–972

    CAS  PubMed  Google Scholar 

  • Eckersley RM (2008) Never better—or getting worse? The health and wellbeing of young Australians. Australia 21

  • Edwards J, McGorry P (2002) Implementing early intervention in psychosis: a guide to establishing early psychosis services. Martin Dunitz, London

    Google Scholar 

  • Egeland JA, Hostetter AM, Pauls DL, Sussex JN (2000) Prodromal symptoms before onset of manic-depressive disorder suggested by first hospital admission histories. J Am Acad Child Adolesc Psychiatry 39(10):1245–1252

    CAS  PubMed  Google Scholar 

  • Emsley R, Myburgh C, Oosthuizen P, van Rensburg SJ (2002) Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry 159(9):1596–1598

    PubMed  Google Scholar 

  • Farooq S, Large M, Nielssen O (2009) Early intervention in psychosis in developing coun-tries: evidence and action. World Psychiatry 8(2):123

    PubMed  PubMed Central  Google Scholar 

  • Fava G, Tossani E (2007) Prodromal stage of major depression. Early Interven Psychiatry 1(1):9–18

    Google Scholar 

  • Fenton WS, Dickerson F, Boronow J, Hibbeln JR, Knable M (2001) A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 158(12):2071–2074

    CAS  PubMed  Google Scholar 

  • Fowler D, Hodgekins J, Painter M, Reilly T, Crane C, Macmillan I, Mugford M, Croudace T and Jones PB (2009) Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychol Med 1–10

  • Fraser R, Berger G, Killackey E, McGorry P (2006) Emerging psychosis in young people—Part 3—key issues for prolonged recovery. Aust Fam Physician 35(5):329–333

    PubMed  Google Scholar 

  • Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE Jr, Marangell LB, Richardson AJ, Lake J, Stoll AL (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67(12):1954–1967

    CAS  PubMed  Google Scholar 

  • Fusar-Poli P, Valmaggia L, McGuire P (2007) Can antidepressants prevent psychosis? Lancet 370(9601):1746–1748

    PubMed  Google Scholar 

  • Garber J, Clarke GN, Weersing VR, Beardslee WR, Brent DA, Gladstone TR, DeBar LL, Lynch FL, D’Angelo E, Hollon SD, Shamseddeen W, Iyengar S (2009) Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA 301(21):2215–2224

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gleeson JF, Cotton SM, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, Pearce T, Newman B, Spiliotacopoulos D, Castle D, McGorry PD (2009) A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. J Clin Psychiatry 70(4):477–486

    PubMed  Google Scholar 

  • Hafner H, Maurer K, Loffler W, Riecher-Rossler A (1993) The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 162:80–86

    CAS  PubMed  Google Scholar 

  • Hafner H, Maurer K, Loffler W, an der Heiden W, Hambrecht M, Schultze-Lutter F (2003) Modeling the early course of schizophrenia. Schizophr Bull 29(2):325–340

    PubMed  Google Scholar 

  • Hafner H, Maurer K, Trendler G, an der Heiden W, Schmidt M (2005) The early course of schizophrenia and depression*. Eur Arch Psychiatry Clin Neurosci 255(3):167–173

    PubMed  Google Scholar 

  • Harrigan SM, McGorry PD, Krstev H (2003) Does treatment delay in first-episode psychosis really matter? Psychol Med 33(1):97–110

    CAS  PubMed  Google Scholar 

  • Harrington R, Clark A (1998) Prevention and early intervention for depression in adolescence and early adult life. Eur Arch Psychiatry Clin Neurosci 248(1):32–45

    CAS  PubMed  Google Scholar 

  • Harris MG, Henry LP, Harrigan SM, Purcell R, Schwartz OS, Farrelly SE, Prosser AL, Jackson HJ, McGorry PD (2005) The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res 79(1):85–93

    PubMed  Google Scholar 

  • Hetrick S, Simmons M, Merry S (2008a) SSRIs and depression in children and adolescents: the imperative for shared decision-making. Australas Psychiatry 16(5):354–358

    PubMed  Google Scholar 

  • Hetrick SE, Parker AG, Hickie IB, Purcell R, Yung AR, McGorry PD (2008b) Early identification and intervention in depressive disorders: towards a clinical staging model. Psychother Psychosom 77(5):263–270

    CAS  PubMed  Google Scholar 

  • Huber G, Gross G, Schuttler R (1979) Schizophrenie. Verlaufs- und sozialpsychiatrische Langzeituntersuchungen an den 1945–1959 in Bonn hospitalisierten schizophrenen Kranken. Springer, Bonn

    Google Scholar 

  • Insel TR (2007) The arrival of preemptive psychiatry. Early Interven Psychiatry 1(1):5–6

    Google Scholar 

  • International Early Psychosis Writing Group (2005) International clinical practice guidelines for early psychosis. Br J Psychiatry 187(suppl):s120–s124

    Google Scholar 

  • Jackson HJ, McGorry PD, Killackey E, Bendall S, Allott K, Dudgeon P, Gleeson J, Johnson T, Harrigan S (2008) Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project. Psychol Med 38(5):725–735

    CAS  PubMed  Google Scholar 

  • Jansson LB, Parnas J (2007) Competing definitions of schizophrenia: what can be learned from polydiagnostic studies? Schizophr Bull 33(5):1178–1200

    PubMed  Google Scholar 

  • Jaycox LH, Reivich KJ, Gillham J, Seligman ME (1994) Prevention of depressive symptoms in school children. Behav Res Ther 32(8):801–816

    CAS  PubMed  Google Scholar 

  • Johannessen JO, McGlashan TH, Larsen TK, Horneland M, Joa I, Mardal S, Kvebaek R, Friis S, Melle I, Opjordsmoen S, Simonsen E, Ulrik H, Vaglum P (2001) Early detection strategies for untreated first-episode psychosis. Schizophr Res 51(1):39–46

    CAS  PubMed  Google Scholar 

  • Johannessen JO, Larsen TK, Joa I, Melle I, Friis S, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan TH (2005) Pathways to care for first-episode psychosis in an early detection healthcare sector: part of the Scandinavian TIPS study. Br J Psychiatry Suppl 48:s24–s28

    PubMed  Google Scholar 

  • Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, Lopez-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rossler A, Grobbee DE (2008) Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371(9618):1085–1097

    CAS  PubMed  Google Scholar 

  • Keshavan MS, Amirsadri A (2007) Early intervention in schizophrenia: current and future perspectives. Curr Psychiatry Rep 9(4):325–328

    PubMed  Google Scholar 

  • Kessing LV, Hansen MG, Andersen PK (2004) Course of illness in depressive, bipolar disorders. Naturalistic study, 1994–1999. Br J Psychiatry 185:372–377

    PubMed  Google Scholar 

  • Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):593–602

    PubMed  Google Scholar 

  • Killackey E, McGorry P (2008) Interventions in the early stages of psychosis. Psychiatr Ann 38(8):521–527

    Google Scholar 

  • Killackey EJ, Jackson HJ, Gleeson J, Hickie IB, McGorry PD (2006) Exciting career opportunity beckons! Early intervention and vocational rehabilitation in first-episode psychosis: employing cautious optimism. Aust N Z J Psychiatry 40(11–12):951–962

    PubMed  Google Scholar 

  • Killackey E, Jackson HJ, McGorry PD (2008) Vocational intervention in first-episode psychosis: individual placement and support v. treatment as usual. Br J Psychiatry 193(2):114–120

    PubMed  Google Scholar 

  • Larsen TK, Friis S, Haahr U, Joa I, Johannessen JO, Melle I, Opjordsmoen S, Simonsen E, Vaglum P (2001) Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand 103(5):323–334

    CAS  PubMed  Google Scholar 

  • Larsen TK, Melle I, Auestad B, Friis S, Haahr U, Johannessen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T (2006) Early detection of first-episode psychosis: the effect on 1-year outcome. Schizophr Bull 32(4):758–764

    PubMed  PubMed Central  Google Scholar 

  • Laurens KR, Hodgins S, Maughan B, Murray RM, Rutter ML, Taylor EA (2007) Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9–12 years. Schizophr Res 90(1–3):130–146

    PubMed  Google Scholar 

  • Lenior ME, Dingemans PM, Linszen DH, de Haan L, Schene AH (2001) Social functioning and the course of early-onset schizophrenia: five-year follow-up of a psychosocial intervention. Br J Psychiatry 179:53–58

    CAS  PubMed  Google Scholar 

  • Lewinsohn PM, Seeley JR, Klein DN (2003). Bipolar disorders during adolescence. Acta Psychiatr Scand Suppl 418:47–50

    Google Scholar 

  • Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M (2005) Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62(4):361–370

    CAS  PubMed  Google Scholar 

  • Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T (2005) Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 62(9):975–983

    PubMed  Google Scholar 

  • Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V (2004) Risk factors for transition to first episode psychosis among individuals with ‘at-risk mental states’. Schizophr Res 71(2–3):227–237

    PubMed  Google Scholar 

  • McGlashan TH (1998) Early detection and intervention of schizophrenia: rationale and research. Br J Psychiatry Suppl 172(33):3–6

    CAS  PubMed  Google Scholar 

  • McGlashan TH (1999) Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry 46(7):899–907

    CAS  PubMed  Google Scholar 

  • McGlashan T, Zipursky R, Perkins D, Addington J, Wood SJ, Miller T, Hawkins KA, Breier A (2004) Olanzapine for the treatment of schizophrenia prodrome: 2 year results of a randomized placebo controlled trial. World J Biol Psychiatry 5(Suppl 1):146

    Google Scholar 

  • McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A (2006) Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 163(5):790–799

    PubMed  Google Scholar 

  • McGorry PD, Yung AR (2003) Early intervention in psychosis: an overdue reform. Aust N Z J Psychiatry 37(4):393–398

    PubMed  Google Scholar 

  • McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ (1996) EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 22(2):305–326

    CAS  PubMed  Google Scholar 

  • McGorry P, Phillips L, Yung A (2001) Recognition and treatment of the pre-psychotic phase of the psychotic disorders: frontier or fantasy? In: Miller T, Mednick S, McGlashan T, Libiger J, Johanssen J (eds) Early intervention in psychiatric disorders. Kluwer, Amsterdam, pp 101–122

    Google Scholar 

  • McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H (2002) Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59(10):921–928

    PubMed  Google Scholar 

  • McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2006) Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 40(8):616–622

    PubMed  Google Scholar 

  • McGorry P, Phillips L, Nelson B, Leicester S, Baker K, Krstev H et al (2007a) A double-blind, placebo controlled randomized trial of low-dose risperidone, cognitive-behavioural therapy, and befriending in young people with subthreshold symptoms at incipient risk of psychotic disorder: six month outcome data. Schizophr Bull 33(2):446

    Google Scholar 

  • McGorry PD, Purcell R, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2007b) Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust 187(7 Suppl):S40–S42

    PubMed  Google Scholar 

  • McGorry PD, Killackey E, Yung A (2008a) Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 7(3):148–156

    PubMed  PubMed Central  Google Scholar 

  • McGorry PD, Yung AR, Bechdolf A, Amminger P (2008b) Back to the future: predicting and reshaping the course of psychotic disorder. Arch Gen Psychiatry 65(1):25–27

    PubMed  Google Scholar 

  • McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, Riecher-Rossler A, Klosterkotter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, McGuire P, Berk M, Chen EY, Keshavan MS and Yung AR (2009) Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiatry 70(9):1206–1212

    PubMed  Google Scholar 

  • Melle I, Larsen TK, Friis S, Vaglum P, Johannessen JO, Simonsen E, Haahr U, Opjordsmoen S, Rund BR, Rossberg J, Joa I, Hegelstad H, Langeveld H, Evensen J, McGlashan T (2009) Early detection of first psychosis: TIPS sample five-year outcomes. Schizophr Bull 35(Suppl 1):330

    Google Scholar 

  • Mihalopoulos C, Harris M, Henry L, Harrigan S, McGorry P (2009) Is early intervention in psychosis cost-effective over the long term? Schizophr Bull 35(5):909–918

    PubMed  PubMed Central  Google Scholar 

  • Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, Woods SW (2002) Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 159(5):863–865

    PubMed  Google Scholar 

  • Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 185:291–297

    PubMed  Google Scholar 

  • Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, Lewis SW (2007) Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull 33(3):682–687

    PubMed  Google Scholar 

  • Nordentoft M, Thorup A, Petersen L, Ohlenschlaeger J, Melau M, Christensen TO, Krarup G, Jorgensen P, Jeppesen P (2006) Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr Res 83(1):29–40

    PubMed  Google Scholar 

  • Parsons B, Allison DB, Loebel A, Williams K, Giller E, Romano S, Siu C (2009) Weight effects associated with antipsychotics: a comprehensive database analysis. Schizophr Res 110(1–3):103–110

    PubMed  Google Scholar 

  • Paus T, Keshavan M, Giedd JN (2008) Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 9(12):947–957

    CAS  PubMed  PubMed Central  Google Scholar 

  • Peet M, Stokes C (2005) Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 65(8):1051–1059

    CAS  PubMed  Google Scholar 

  • Perkins DO, Gu H, Boteva K, Lieberman JA (2005) Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 162(10):1785–1804

    PubMed  Google Scholar 

  • Phillips LJ, McGorry PD, Yuen HP, Ward J, Donovan K, Kelly D, Francey SM, Yung AR (2007) Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res 96(1–3):25–33

    PubMed  Google Scholar 

  • Phillips L, Nelson B, Yuen HP, Francey S, Simmons M, Stanford C (2009) Randomized controlled trial of interventions for young people at UHR of psychosis: study design and baseline characteristics. Aust N Z J Psychiatry 43(9):818–829

    PubMed  Google Scholar 

  • Power P, Iacoponi E, Reynolds N, Fisher H, Russell M, Garety P, McGuire PK, Craig T (2007) The Lambeth Early Onset Crisis Assessment Team Study: general practitioner education and access to an early detection team in first-episode psychosis. Br J Psychiatry Suppl 51:s133–s139

    PubMed  Google Scholar 

  • Regier DA, Narrow WE, Kuhl EA, Kupfer DJ (2009) The conceptual development of DSM-V. Am J Psychiatry 166(6):645–650

    PubMed  Google Scholar 

  • Riecher-Rossler A, Gschwandtner U, Aston J, Borgwardt S, Drewe M, Fuhr P, Pfluger M, Radu W, Schindler C, Stieglitz RD (2007) The Basel early-detection-of-psychosis (FEPSY)-study–design and preliminary results. Acta Psychiatr Scand 115(2):114–125

    CAS  PubMed  Google Scholar 

  • Ruhrmann S, Schultze-Lutter F, Klosterkotter J (2003) Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry 36(Suppl 3):S162–S167

    PubMed  Google Scholar 

  • Seeley JR, Stice E, Rohde P (2009) Screening for depression prevention: identifying adolescent girls at high risk for future depression. J Abnorm Psychol 118(1):161–170

    PubMed  PubMed Central  Google Scholar 

  • Stice E, Burton E, Bearman SK, Rohde P (2007) Randomized trial of a brief depression prevention program: an elusive search for a psychosocial placebo control condition. Behav Res Ther 45(5):863–876

    PubMed  Google Scholar 

  • Stice E, Rohde P, Seeley JR, Gau JM (2008) Brief cognitive-behavioral depression prevention program for high-risk adolescents outperforms two alternative interventions: a randomized efficacy trial. J Consult Clin Psychol 76(4):595–606

    PubMed  PubMed Central  Google Scholar 

  • Sullivan HS (1927) The onset of schizophrenia. Am J Psychiatry 6:105–134

    Google Scholar 

  • Thompson KN, Conus PO, Ward JL, Phillips LJ, Koutsogiannis J, Leicester S, McGorry PD (2003) The initial prodrome to bipolar affective disorder: prospective case studies. J Affect Disord 77(1):79–85

    PubMed  Google Scholar 

  • Woods SW, Walsh BC, Pearlson GD, McGlashan T (2006) Glycine treatment of prodromal symptoms. Schizophr Res 86:s7–s17

    Google Scholar 

  • Woods SW, Tully EM, Walsh BC, Hawkins KA, Callahan JL, Cohen SJ, Mathalon DH, Miller TJ, McGlashan TH (2007) Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study. Br J Psychiatry Suppl 51:s96–s101

    PubMed  Google Scholar 

  • Wykes T, Newton E, Landau S, Rice C, Thompson N, Frangou S (2007) Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophr Res 94(1–3):221–230

    PubMed  Google Scholar 

  • Yung AR (2003) The schizophrenia prodrome: a high-risk concept. Schizophr Bull 29(4):859–865

    PubMed  Google Scholar 

  • Yung AR, McGorry PD (1996a) The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry 30(5):587–599

    CAS  PubMed  Google Scholar 

  • Yung AR, McGorry PD (1996b) The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 22(2):353–370

    CAS  PubMed  Google Scholar 

  • Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, Patton GC, Jackson HJ (1998) Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl 172(33):14–20

    CAS  PubMed  Google Scholar 

  • Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD (2003) Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res 60(1):21–32

    PubMed  Google Scholar 

  • Yung AR, Phillips LJ, McGorry PD (2004a) Treating schizophrenia in the prodromal phase. Taylor and Francis, London

    Google Scholar 

  • Yung AR, Phillips LJ, Yuen HP, McGorry PD (2004b) Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 67(2–3):131–142

    PubMed  Google Scholar 

  • Yung AR, Buckby JA, Cosgrave EM, Killackey EJ, Baker K, Cotton SM, McGorry PD (2007a) Association between psychotic experiences and depression in a clinical sample over 6 months. Schizophr Res 91(1–3):246–253

    PubMed  Google Scholar 

  • Yung AR, McGorry PD, Francey SM, Nelson B, Baker K, Phillips LJ, Berger G, Amminger GP (2007b) PACE: a specialised service for young people at risk of psychotic disorders. Med J Aust 187(7 Suppl):S43–S46

    PubMed  Google Scholar 

  • Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, Phillips L, McGorry P (2007c) Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 33(3):673–681

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Professor McGorry receives funding from the Colonial Foundation, and from a Program Grant and a Clinical Centre Research Excellence Grant from the National Health and Medical Research Council of Australia. He has also received research grant support from Janssen Cilag Eli Lilly, Pfizer, Novartis and Astra Zeneca.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick D. McGorry.

About this article

Cite this article

McGorry, P.D. RETRACTED ARTICLE: Staging in Neuropsychiatry: A Heuristic Model for Understanding, Prevention and Treatment. Neurotox Res 18, 244–255 (2010). https://doi.org/10.1007/s12640-010-9179-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12640-010-9179-x

Keywords

Navigation